BDBM772070 US20250289804, Example 17

SMILES COc1cc(C)c2[nH]ccc2c1CN1CC[C@H](NC2COC2)C[C@H]1c1ccc(C(=O)O)cc1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 772070   

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandPNGBDBM772070(US20250289804, Example 17)
Affinity DataIC50: 150nMAssay Description:Compounds disclosed herein were evaluated for their potency to inhibit human C3bBb in a biochemical assay. To generate active C3bBb complex in vitro,...More data for this Ligand-Target Pair
Target InfoPDB
GoogleScholar
Ligand Info
In Depth
Date in BDB:
1/3/2026
Entry Details
US Patent